Advances in Radiation Oncology in Lung Cancer

Front Cover
Branislav Jeremic
Springer Science & Business Media, Sep 18, 2011 - Medical - 843 pages

This is the second, completely updated edition of a comprehensive book in which many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research findings. The first three sections cover the basic science of lung cancer, clinical investigations, including histology and staging, and a wide range of fundamental treatment considerations. Current treatment strategies for small cell and non-small cell lung cancer are then explained and evaluated in detail, with due attention to novel approaches that promise further improvements in outcome. The various types of treatment-related toxicity are discussed, and quality of life studies and prognostic factors are also considered. After evaluating the latest technological and biological advances, including IMRT, IMAT, cyber knife treatment, and tomotherapy, the book concludes by thorough consideration of specific aspects of clinical research in lung cancer.

 

Contents

252 Prophylactic Cranial Irradiation
445
316 Palliative External Beam Thoracic Radiation Therapy of NonSmall Cell Lung Cancer
453
Methodology Electrons or Brachytherapy Clinical Experiences and LongTerm Institutional Results
460
311 Brachytherapy for Lung Cancer
477
Part VI Current Treatment Strategies in Small Cell Lung Cancer
489
253 LimitedDisease SmallCell Lung Cancer
491
208 Radiation Therapy in Extensive Disease Small Cell Lung Cancer
505
270 Prophylactic Cranial Irradiation in SmallCell Lung Cancer
513

261 Surgical Staging of Lung Cancer for Advances in Radiation Oncology of Lung Cancer
89
Part III Basic Treatment Considerations
100
318 Lung Cancer Surgery
101
250 Radiation Response of the Normal Lung Tissue and Lung Tumors
119
268 Radiation Time Dose and Fractionation in the Treatment of Lung Cancer
129
302 3D Radiation Treatment Planning and Execution
142
A Clinical Perspective
157
300 PET and PETCT in Treatment Planning
173
231 Target Volume Definition in NonSmall Cell Lung Cancer
187
251 The Radiation Target in SmallCell Lung Cancer
201
278 Radiation Sensitizers
213
288 Radioprotectors and Chemoprotectors in the Management of Lung Cancer
223
307 Systemic Therapy for Lung Cancer for the Radiation Oncologist
247
Theoretical Considerations and Biological Premises
267
272 Radiotherapy and Second Generation Drugs
274
269 Radiotherapy and Third Generation Concurrent Chemotherapy Agents
291
Part IV Current Treatment Strategies In EarlyStage NonSmall Cell Lung Cancer
313
207 Conventional Radiation Therapy in Early Stage Nonsmallcell Lung Cancer
315
258 Stereotactic Ablative Radiotherapy for Early Stage Lung Cancer
342
315 Postoperative Radiotherapy for NonSmall Cell Carcinoma
363
220 PDTLung
371
230 The Role of Radiofrequency Ablation in the Treatment of Stage 1 NonSmall Cell Lung Cancer
381
Part V Current Treatment Strategies in Locally Advanced NonSmall Cell Lung Cancer
396
298 Lung Dose Escalation
399
232 Radiochemotherapy in Locally Advanced NonsmallCell Lung Cancer
409
306 TriModality Therapy in Locally Advanced NonSmallCell Lung Cancer
432
Part VII Treatment in Specific Patient Groups and Other Settings
521
254 Radiation Therapy for Lung Cancer in Elderly
523
255 Radiation Therapy for Recurrent Disease
543
275 Radiation Therapy for Metastatic Disease
560
313 Advances in Supportive and Palliative Care for Lung Cancer Patients
575
Part VIII TreatmentRelated Toxicity
594
Part IX Quality of Life Studies and Prognostic Factors
659
259 Quality of Life Outcomes in Radiotherapy of Lung Cancer
660
308 Prognostic Factors in Lung Cancer
675
Part X Technological Advances in Lung Cancer
689
283 IntensityModulated Radiation Therapy and VolumetricModulated Arc Therapy for Lung Cancer
690
The CyberKnife
715
277 Advances in Radiation Oncology of Lung Cancer
725
287 ImageGuided Radiotherapy in Lung Cancer
735
State of the Science
743
257 Carbon Ion Radiotherapy in HypoFractionation Regimen and Single Dose for Stage I NonsmallCell Lung Cancer
753
Part XI Biological Advances in Lung Cancer
764
Focus on Pemetrexed and NabPaclitaxel Abraxane
765
312 Novel Targeted Agents and Radiopharmaceuticals in Lung Cancer
773
Part XII Clinical Research in Lung Cancer
791
296 Translational Research in Lung Cancer
792
Why We Failed?
809
282 Pitfalls in the Design Analysis Presentation and Interpretation of Randomized Clinical Trials
819
299 New Directions in the Evaluation and Presentation of Clinical Research in Lung Cancer
827
Index
837
Copyright

Other editions - View all

Common terms and phrases

Bibliographic information